Comparative Efficacy and Safety of Low-dose Fluticasone Propionate and Montelukast in Children with Persistent Asthma

This publication has 36 references indexed in Scilit:

• Low-Dose Inhaled Corticosteroid Therapy and Risk of Emergency Department Visits for Asthma
  Archives of internal medicine (1960), 2002
• Impact of Inhaled Antiinflammatory Therapy on Hospitalization and Emergency Department Visits for Children With Asthma
  Pediatrics, 2001
• Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma
  Annals of Allergy, Asthma & Immunology, 2000
• Low-Dose Inhaled Corticosteroids and the Prevention of Death from Asthma
  New England Journal of Medicine, 2000
• The Effect of Inhaled Fluticasone Propionate in the Treatment of Young Asthmatic Children
  American Journal of Respiratory and Critical Care Medicine, 1999
• Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma
  Journal of Allergy and Clinical Immunology, 1998
• Fluticasone propionate 50 μg BID versus 100 μg BID in the treatment of children with persistent asthma
  Clinical Therapeutics, 1998
• Montelukast for Chronic Asthma in 6- to 14-Year-Old Children
  JAMA, 1998
• Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study.
  American Journal of Respiratory and Critical Care Medicine, 1997
• A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial
  Journal of Allergy and Clinical Immunology, 1992